Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Schwab Fundamental US Large Company Index ETF
FNDX
|
+$8.54B |
| 2 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
+$6.22B |
| 3 |
Schwab US Large- Cap ETF
SCHX
|
+$6.12B |
| 4 |
Schwab Fundamental US Small Company Index ETF
FNDA
|
+$5.39B |
| 5 |
Schwab 5-10 Year Corporate Bond ETF
SCHI
|
+$5.01B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Texas Instruments
TXN
|
+$367M |
| 2 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$335M |
| 3 |
Diageo
DEO
|
+$297M |
| 4 |
Medtronic
MDT
|
+$259M |
| 5 |
GE Aerospace
GE
|
+$222M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.36% |
| 2 | Financials | 10.66% |
| 3 | Healthcare | 9.68% |
| 4 | Consumer Discretionary | 8.35% |
| 5 | Industrials | 7.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3451
McEwen Inc
MUX
$1B
| $172K | ﹤0.01% |
18,704
| – | – |
|
3452
OppFi
OPFI
$813M
| $169K | ﹤0.01% |
49,961
+17,716
| +55% | +$53.9K |
|
|
HYZN
3453
DELISTED
Hyzon Motors Inc. Class A Common Stock
HYZN
| $167K | ﹤0.01% |
10,372
+69
| +0.7% | +$1.92K |
|
3454
NLI Holdings
NL
$289M
| $155K | ﹤0.01% |
25,715
+1,097
| +4% | +$8.19K |
|
3455
Amprius Technologies
AMPX
$1.2B
| $155K | ﹤0.01% |
121,945
+22,396
| +22% | +$36.5K |
|
3456
Strawberry Fields REIT
STRW
$195M
| $153K | ﹤0.01% |
+13,400
| New | +$131K |
|
|
GOCO
3457
DELISTED
GoHealth
GOCO
| $149K | ﹤0.01% |
15,371
+3,099
| +25% | +$30.7K |
|
3458
Gevo
GEVO
$353M
| $148K | ﹤0.01% |
266,014
-266,275
| -50% | -$178K |
|
3459
Galectin Therapeutics
GALT
$230M
| $147K | ﹤0.01% |
65,073
+47,660
| +274% | +$145K |
|
3460
Ramaco Resources Class B
METCB
$423M
| $139K | ﹤0.01% |
13,765
| – | – |
|
|
MRDN
3461
Meridian Holdings Inc
MRDN
$139M
| $137K | ﹤0.01% |
+4,608
| New | +$211K |
|
3462
Forafric Global
AFRI
$281M
| $127K | ﹤0.01% |
11,937
| – | – |
|
|
DADA
3463
DELISTED
Dada Nexus
DADA
| $126K | ﹤0.01% |
99,704
-812
| -0.8% | -$1.46K |
|
3464
Ovid Therapeutics
OVID
$427M
| $124K | ﹤0.01% |
161,808
| – | – |
|
3465
Drilling Tools International
DTI
$80.5M
| $124K | ﹤0.01% |
+22,082
| New | +$119K |
|
3466
Workhorse Group
WKHS
$33.4M
| $123K | ﹤0.01% |
521
-163
| -24% | -$85.5K |
|
|
CLYM
3467
Climb Bio
CLYM
$693M
| $122K | ﹤0.01% |
+17,128
| New | +$114K |
|
|
BINI
3468
DELISTED
Bollinger Innovations
BINI
| – | – |
0
| – | – |
|
3469
MarketWise
MKTW
$54.6M
| $113K | ﹤0.01% |
4,889
+1,268
| +35% | +$37.4K |
|
3470
FTC Solar
FTCI
$41.6M
| $108K | ﹤0.01% |
30,522
-14,344
| -32% | -$67.9K |
|
3471
Solarmax Technology
SMXT
$20.5M
| $107K | ﹤0.01% |
+32,585
| New | +$291K |
|
|
CLPR
3472
Clipper Realty
CLPR
$46.4M
| $107K | ﹤0.01% |
29,696
| – | – |
|
|
VXRT
3473
DELISTED
Vaxart
VXRT
| $102K | ﹤0.01% |
153,587
+40
| +0% | +$33 |
|
|
BRDG
3474
DELISTED
Bridge Investment Group
BRDG
| $99.3K | ﹤0.01% |
13,376
| – | – |
|
|
UHG
3475
DELISTED
United Homes Group
UHG
| $99K | ﹤0.01% |
17,396
| – | – |
|
Similar funds
Charles Schwab's Q2 2024 Portfolio in Review
As of Q2 2024, Charles Schwab held 3,738 positions worth $525B, up 21% from $433B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Charles Schwab deployed $84.3B of net new capital in Q2 2024, opening 263 new positions and adding to 2,391 existing holdings. Its largest new stake was Schwab Fundamental US Small Company Index ETF: 195,294,508 shares worth $5.36B.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 23% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Texas Instruments, an estimated $367M trimmed.
- Charles Schwab's largest Q2 2024 buy was Schwab Fundamental US Small Company Index ETF: 195,294,508 shares worth $5.36B.
- Charles Schwab added most to Schwab Fundamental US Large Company Index ETF in Q2 2024, an estimated $8.54B increase.
- Charles Schwab's biggest Q2 2024 reduction was Texas Instruments, cutting an estimated $367M.
- Charles Schwab fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $335M.
- Charles Schwab's ten largest holdings make up 21% of its $525B portfolio in Q2 2024.
- Charles Schwab opened 263 new positions and closed 116 in Q2 2024.
- Charles Schwab's portfolio value rose 21% quarter-over-quarter to $525B.
Based on Charles Schwab's 13F filing for Q2 2024, filed 12 Aug 2024.